Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?
26/09/2024
Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are...
read more
Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints
19/09/2024
Pharma companies have been increasingly investing in developing targeted alpha therapies for cancer treatment, using alpha-emitting isotopes such as Ac-225....
read more
Neuromarketing: How Brands Are Leveraging Brain Science to Decode Your Desires
12/09/2024
Innovative marketing strategies have become highly important for businesses in today’s crowded markets, where there is abundant competition and consumers...
read more
What’s Fueling Asia’s Drive to Develop Wholesale CBDCs?
22/08/2024
The emergence of Central Bank Digital Currencies (CBDCs) has become a central focus in the global financial space, as it...
read more
Prescribing Security: Diagnosing and Treating the IoT Universe in Healthcare
14/08/2024
The integration of the Internet of Things (IoT) into the healthcare industry has significantly transformed the delivery of medical services,...
read more
Lessons for Africa: To-do’s from India’s Successful Vaccine Journey
25/07/2024
India, still a developing country, has achieved tremendous success as the world's largest vaccine producer. This accomplishment leads to many...
read more
Why Can India’s Vaccine Success Story Be a Sure Shot Template for Africa?
18/07/2024
Africa is currently facing significant challenges related to limited accessibility to vaccines as well as ongoing vaccine hesitancy. African CDC...
read more
Charting the RegTech Journey: Navigating Consolidation
09/07/2024
RegTech, short for regulatory technology and often categorized as a subset of fintech, emerged in 2015. The RegTech industry was...
read more
Pet Wearables – Are Companies Barking Up the Right Technology?
28/06/2024
As the human wearables market begins to mature, a lot of interest and developments are also happening in the pet...
read more
IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?
20/06/2024
The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the...
read more